Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer‐induced cachexia
Abstract Background Cancer patients who exhibit cachexia lose weight and have low treatment tolerance and poor outcomes compared with cancer patients without weight loss. Despite the clear increased risk for patients, diagnosing cachexia still often relies on self‐reported weight loss. A reliable bi...
Saved in:
Main Authors: | Jeffery M. Chakedis (Author), Mary E. Dillhoff (Author), Carl R. Schmidt (Author), Priyani V. Rajasekera (Author), David C. Evans (Author), Terence M. Williams (Author), Denis C. Guttridge (Author), Erin E. Talbert (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients
by: Erin E. Talbert, et al.
Published: (2018) -
Sexual dimorphism in developmental and diet‐dependent circulating retinol binding protein 4
by: S. Bakshi, et al.
Published: (2018) -
Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
by: Jeffrey S. Damrauer, et al.
Published: (2018) -
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
by: Xiaoling Zhong, et al.
Published: (2019) -
Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations
by: Sharon Cresci, et al.
Published: (2020)